# Mustang Bio, Inc.: Form 8-K, filed Jul 3, 2024

- Company: [Mustang Bio, Inc.](/companies/mbio.md) (CIK 1680048)
- Form: 8-K
- Filed: 2024-07-03
- Accepted by EDGAR: Jul 3, 2024, 08:55 ET
- Period: 2024-06-27
- Accession: 0001104659-24-077596
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1680048/000110465924077596/tm2418844d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1680048/000110465924077596/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 1.02: Termination of a material agreement
- Item 2.01: Completion of an acquisition or disposition
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1680048/000110465924077596/tm2418844d1_8k.htm

Filed Jul 3, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-077596. Last ingested by Listed: Nov 5, 2026, 20:48 ET. No prices; not investment advice.